港股估值修复窗口下的高视医疗:低估值,重研发,高韧性

新浪财经
Yesterday

近日, 高视医疗 (2407.HK)发布了2024财年利润状况公告,透过数据表象,公司经营韧性、技术布局与港股市场环境的多重积极信号正逐渐浮出水面。一、下半年业绩环比改善,释放复苏动能公司2024年上半年净利润同比下滑约75%,全年净利润预计减少 49.7%-54.4%,表明下半年已显著回暖。下半年利润状况改善,得益于其在销售端的积极作为。公司凭借成熟的渠道网络、优质的服务和灵活的产品组合策略,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10